Functional and histological consequences of quinolinic and kainic acid-induced seizures on hippocampal somatostatin neurons

A. Manfridi, G. L. Forloni, A. Vezzani, F. Fodritto, M. G. De Simoni

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Changes in endogenous somatostatin after quinolinic and kainic acids were investigated by measuring somatostatin-like peaks by in vivo voltammetry and by assessing the distribution of somatostatin-positive neurons by immunocytochemistry. Kainic acid (0.19 nmol/0.5 μl) or quinolinic acid (120 nmol/0.5 μl) in doses inducing comparable electroencephalographic seizure patterns, were injected into the hippocampus of freely moving rats. Somatostatin-like peaks were measured every 6 min for 3 h by a carbon fiber electrode implanted in the proximity of the injection needle. Kainic acid kept somatostatin-like peaks significantly higher than saline from 48 min after the injection till the end of the recording. Somatostatin-like peaks were dramatically elevated by quinolinic acid, reaching a maximum of 482% 60 min after the injection. Three days later, administration of kainic acid resulted in selective degeneration of CA3 pyramidal neurons but did not affect the number of somatostatin-positive cells, while quinolinic acid induced cell loss in all pyramidal layers and complete degeneration of somatostatin-positive cells in the whole hippocampus. Thus, the quantitative difference in somatostatin release in response to doses of kainic and quinolinic acids inducing comparable electroencephalographic seizure patterns was reflected in a substantial difference in the neurodegenerative consequences. In both models, the release of somatostatin in response to seizures may be interpreted as a "defense" mechanism aimed at reducing the spread of excitation in the tissue.

Original languageEnglish
Pages (from-to)127-135
Number of pages9
JournalNeuroscience
Volume41
Issue number1
DOIs
Publication statusPublished - 1991

Fingerprint

Quinolinic Acid
Somatostatin
Seizures
Neurons
Quinolinic Acids
Kainic Acid
Somatostatin-Secreting Cells
Injections
Hippocampus
Implanted Electrodes
Pyramidal Cells
Needles
Immunohistochemistry

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

@article{d154e82e3f6946e9b891338ce6f84595,
title = "Functional and histological consequences of quinolinic and kainic acid-induced seizures on hippocampal somatostatin neurons",
abstract = "Changes in endogenous somatostatin after quinolinic and kainic acids were investigated by measuring somatostatin-like peaks by in vivo voltammetry and by assessing the distribution of somatostatin-positive neurons by immunocytochemistry. Kainic acid (0.19 nmol/0.5 μl) or quinolinic acid (120 nmol/0.5 μl) in doses inducing comparable electroencephalographic seizure patterns, were injected into the hippocampus of freely moving rats. Somatostatin-like peaks were measured every 6 min for 3 h by a carbon fiber electrode implanted in the proximity of the injection needle. Kainic acid kept somatostatin-like peaks significantly higher than saline from 48 min after the injection till the end of the recording. Somatostatin-like peaks were dramatically elevated by quinolinic acid, reaching a maximum of 482{\%} 60 min after the injection. Three days later, administration of kainic acid resulted in selective degeneration of CA3 pyramidal neurons but did not affect the number of somatostatin-positive cells, while quinolinic acid induced cell loss in all pyramidal layers and complete degeneration of somatostatin-positive cells in the whole hippocampus. Thus, the quantitative difference in somatostatin release in response to doses of kainic and quinolinic acids inducing comparable electroencephalographic seizure patterns was reflected in a substantial difference in the neurodegenerative consequences. In both models, the release of somatostatin in response to seizures may be interpreted as a {"}defense{"} mechanism aimed at reducing the spread of excitation in the tissue.",
author = "A. Manfridi and Forloni, {G. L.} and A. Vezzani and F. Fodritto and {De Simoni}, {M. G.}",
year = "1991",
doi = "10.1016/0306-4522(91)90203-Z",
language = "English",
volume = "41",
pages = "127--135",
journal = "Neuroscience",
issn = "0306-4522",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Functional and histological consequences of quinolinic and kainic acid-induced seizures on hippocampal somatostatin neurons

AU - Manfridi, A.

AU - Forloni, G. L.

AU - Vezzani, A.

AU - Fodritto, F.

AU - De Simoni, M. G.

PY - 1991

Y1 - 1991

N2 - Changes in endogenous somatostatin after quinolinic and kainic acids were investigated by measuring somatostatin-like peaks by in vivo voltammetry and by assessing the distribution of somatostatin-positive neurons by immunocytochemistry. Kainic acid (0.19 nmol/0.5 μl) or quinolinic acid (120 nmol/0.5 μl) in doses inducing comparable electroencephalographic seizure patterns, were injected into the hippocampus of freely moving rats. Somatostatin-like peaks were measured every 6 min for 3 h by a carbon fiber electrode implanted in the proximity of the injection needle. Kainic acid kept somatostatin-like peaks significantly higher than saline from 48 min after the injection till the end of the recording. Somatostatin-like peaks were dramatically elevated by quinolinic acid, reaching a maximum of 482% 60 min after the injection. Three days later, administration of kainic acid resulted in selective degeneration of CA3 pyramidal neurons but did not affect the number of somatostatin-positive cells, while quinolinic acid induced cell loss in all pyramidal layers and complete degeneration of somatostatin-positive cells in the whole hippocampus. Thus, the quantitative difference in somatostatin release in response to doses of kainic and quinolinic acids inducing comparable electroencephalographic seizure patterns was reflected in a substantial difference in the neurodegenerative consequences. In both models, the release of somatostatin in response to seizures may be interpreted as a "defense" mechanism aimed at reducing the spread of excitation in the tissue.

AB - Changes in endogenous somatostatin after quinolinic and kainic acids were investigated by measuring somatostatin-like peaks by in vivo voltammetry and by assessing the distribution of somatostatin-positive neurons by immunocytochemistry. Kainic acid (0.19 nmol/0.5 μl) or quinolinic acid (120 nmol/0.5 μl) in doses inducing comparable electroencephalographic seizure patterns, were injected into the hippocampus of freely moving rats. Somatostatin-like peaks were measured every 6 min for 3 h by a carbon fiber electrode implanted in the proximity of the injection needle. Kainic acid kept somatostatin-like peaks significantly higher than saline from 48 min after the injection till the end of the recording. Somatostatin-like peaks were dramatically elevated by quinolinic acid, reaching a maximum of 482% 60 min after the injection. Three days later, administration of kainic acid resulted in selective degeneration of CA3 pyramidal neurons but did not affect the number of somatostatin-positive cells, while quinolinic acid induced cell loss in all pyramidal layers and complete degeneration of somatostatin-positive cells in the whole hippocampus. Thus, the quantitative difference in somatostatin release in response to doses of kainic and quinolinic acids inducing comparable electroencephalographic seizure patterns was reflected in a substantial difference in the neurodegenerative consequences. In both models, the release of somatostatin in response to seizures may be interpreted as a "defense" mechanism aimed at reducing the spread of excitation in the tissue.

UR - http://www.scopus.com/inward/record.url?scp=0026030674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026030674&partnerID=8YFLogxK

U2 - 10.1016/0306-4522(91)90203-Z

DO - 10.1016/0306-4522(91)90203-Z

M3 - Article

C2 - 1676138

AN - SCOPUS:0026030674

VL - 41

SP - 127

EP - 135

JO - Neuroscience

JF - Neuroscience

SN - 0306-4522

IS - 1

ER -